The prevalence and prognosis of hyponatraemia in non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis

References

• Yildiz H, Van Den Neste E, Defour JP, et al. Adult haemophagocytic lymphohistiocytosis: a review. QJM. 2020;11:hcaa0.
   Google Scholar
• Yildiz H, Bailly S, Van Den Neste E, et al. Clinical management of relapsed/refractory hemophagocytic lymphohistiocytosis in adult patients: a review of current strategies and emerging therapies. Ther Clin Risk Manag. 2021;17:293–304.
   PubMed Web of Science ®Google Scholar
• Castillo L, Carcillo J. Secondary hemophagocytic lymphohistiocytosis and severe sepsis/systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation. Pediatr Critical Care Med. 2009;10(3):387–392.
   PubMed Web of Science ®Google Scholar
• Ramos-Casals M, Brito-Zeron P, Lopez-Guillermo A, et al. Adult haemophagocytic syndrome. Lancet. 2014;383(9927):1503–1516.
   PubMed Web of Science ®Google Scholar
• Forfia PR, Mathai SC, Fisher MR, et al. Hyponatremia predicts right heart failure and poor survival in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2008;177(12):1364–1369.
   PubMed Web of Science ®Google Scholar
• Darmon M, Pichon M, Schwebel C, et al. Influence of early dysnatremia correction on survival of critically ill patients. Shock. 2014;41(5):394–399.
   PubMed Web of Science ®Google Scholar
• Il Shin J, Park SJ, Suh CH, et al. Hyponatremia in patients with systemic lupus erythematosus. Sci Rep. 2016;6:25566.
   PubMed Web of Science ®Google Scholar
• Castillo JJ, Glezerman IG, Boklage SH, et al. The occurrence of hyponatremia and its importance as a prognostic factor in a cross-section of cancer patients. BMC Cancer. 2016;16(1):564.
   PubMedGoogle Scholar
• Cazzola M. Introduction to a review series: the 2016 revision of the WHO classification of tumors of hematopoietic and lymphoid tissues. Blood. 2016;127(20):2361–2364.
   PubMed Web of Science ®Google Scholar
• Liang JH, Wang L, Zhu HY, et al. Dose-adjusted EPOCH regimen as first-line treatment for non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis: a single-arm, open-label, phase II trial. Haematologica. 2020;105(1):e29–e32.
   PubMed Web of Science ®Google Scholar
• Henter JI, Horne A, Arico M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–131.
   PubMed Web of Science ®Google Scholar
• Fardet L, Galicier L, Lambotte O, et al. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis & Rheumatology. 2014;66(9):2613–2620.
   PubMed Web of Science ®Google Scholar
• Andreani G, Carpene E, Cannavacciuolo A, et al. Reference values for hematology and plasma biochemistry variables, and protein electrophoresis of healthy hermann's tortoises (testudo hermanni ssp.). Vet Clin Pathol. 2014;43(4):573–583.
   PubMed Web of Science ®Google Scholar
• Cattaneo C, Oberti M, Skert C, et al. Adult onset hemophagocytic lymphohistiocytosis prognosis is affected by underlying disease and coexisting viral infection: analysis of a single institution series of 35 patients. Hematol Oncol. 2017;35(4):828–834.
   PubMed Web of Science ®Google Scholar
• Yin G, Man C, Liao S, et al. The prognosis role of AST/ALT (De ritis) ratio in patients with adult secondary hemophagocytic lymphohistiocytosis. Mediators Inflamm. 2020;2020:1–10.
   Web of Science ®Google Scholar
• Pokaharel M, Block CA. Dysnatremia in the ICU. Curr Opin Crit Care. 2011;17(6):581–593.
   PubMed Web of Science ®Google Scholar
• Cardenas A, Sola E, Rodriguez E, et al. Hyponatremia influences the outcome of patients with acute-on-chronic liver failure: an analysis of the CANONIC study. Crit Care. 2014;18(6):700.
   PubMed Web of Science ®Google Scholar
• Mrowczynski OD, Bourcier AJ, Liao J, et al. The predictive potential of hyponatremia for glioblastoma patient survival. J Neurooncol. 2018;138(1):99–104.
   PubMed Web of Science ®Google Scholar
• Fiordoliva I, Meletani T, Baleani MG, et al. Managing hyponatremia in lung cancer: latest evidence and clinical implications. Ther Adv Med Oncol. 2017;9(11):711–719.
   PubMed Web of Science ®Google Scholar
• Ciaudo M, Chauvenet L, Audouin J, et al. Peripheral-T-cell lymphoma with hemophagocytic histiocytosis localised to the bone marrow associated with inappropriate secretion of antidiuretic hormone. Leuk Lymphoma. 1995;19(5–6):511–514.
   PubMed Web of Science ®Google Scholar
• Shimizu N, Tanaka S, Watanabe Y, et al. Syndrome of inappropriate antidiuretic hormone secretion in a patient with mucosa-associated lymphoid tissue lymphoma. Intern Med. 2017;56(23):3225–3229.
   PubMed Web of Science ®Google Scholar
• Watabe R, Shibata K, Hirase N, et al. Angiotropic B-cell lymphoma with hemophagocytic syndrome associated with syndrome of inappropriate secretion of antidiuretic hormone. Ann Hematol. 2000;79(10):581–584.
   PubMed Web of Science ®Google Scholar
• Abu Zeinah GF, Al-Kindi SG, Hassan AA, et al. Hyponatraemia in cancer: association with type of cancer and mortality. Eur J Cancer Care (Engl). 2015;24(2):224–231.
   PubMed Web of Science ®Google Scholar
• Lim AKH, Paramaswaran S, Jellie LJ, et al. A Cross-Sectional study of hyponatremia associated with acute Central nervous system infections. JCM. 2019;8(11):1801.
   Google Scholar
• Liamis G, Filippatos TD, Elisaf MS. Electrolyte disorders associated with the use of anticancer drugs. Eur J Pharmacol. 2016;777:78–87.
   PubMed Web of Science ®Google Scholar
• Garcia-Sanz MT, Martinez-Gestoso S, Calvo-Alvarez U, et al. Impact of hyponatremia on COPD exacerbation prognosis. JCM. 2020;9(2):503.
   Google Scholar
• Castillo JJ, Vincent M, Justice E. Diagnosis and management of hyponatremia in cancer patients. Oncologist. 2012;17(6):756–765.
   PubMed Web of Science ®Google Scholar
• Brisse E, Wouters CH, Matthys P. Hemophagocytic lymphohistiocytosis (HLH): a heterogeneous spectrum of cytokine-driven immune disorders. Cytokine Growth Factor Rev. 2015;26(3):263–280.
   PubMed Web of Science ®Google Scholar
• Eisenhut M. Changes in ion transport in inflammatory disease. J Inflamm (Lond). 2006;3:5.
   PubMedGoogle Scholar
• Eisenhut M. Changes in renal sodium transport during a systemic inflammatory response. Pediatr Nephrol. 2006;21(10):1487–1488; author reply 9.
   PubMed Web of Science ®Google Scholar
• Palin K, Moreau ML, Sauvant J, et al. Interleukin-6 activates arginine vasopressin neurons in the supraoptic nucleus during immune challenge in rats. Am J Physiol Endocrinol Metab. 2009;296(6):E1289–99.
   PubMed Web of Science ®Google Scholar
• Park SJ, Shin JI. Inflammation and hyponatremia: an underrecognized condition? Korean J Pediatr. 2013;56(12):519–522.
   PubMedGoogle Scholar
• Hodax JK, Bialo SR, Yalcindag A. SIADH in systemic JIA resolving after treatment with an IL-6 inhibitor. Pediatrics. 2018;141(1):e20164174.
   PubMed Web of Science ®Google Scholar